Impact of Time-To-Surgery on the Prognosis of Patients with T1 Renal Cell Carcinoma: Implications for the COVID-19 PandemicWei Ou, Lingwu Chen, Бин Ли et al.|Journal of Clinical Medicine|2022Cited by 6
Intra-arterial chemotherapy plus BCG, a promising combination adjuvant treatment for high-risk NMIBCShuhang Luo, Bin Huang, Rui Yang et al.|Research Square|2022Cited by 0
PUNCH01: Interim results from a phase II study of intra-arterial chemotherapy (IAC) combined with tislelizumab and bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer (HR NMIBC).Zongren Wang, Junxing Chen, Bin Huang et al.|Journal of Clinical Oncology|2025Cited by 0